Concepedia

Publication | Open Access

The Dapagliflozin And Prevention of Adverse-Outcomes in Heart Failure (DAPA-HF) Trial: Baseline Characteristics

217

Citations

31

References

2019

Year

Abstract

ClinicalTrials.gov Identifier NCT03036124.

References

YearCitations

Page 1